454 related articles for article (PubMed ID: 32597263)
1. Therapeutic drug monitoring of β-lactam antibiotics in the ICU.
Dhaese S; Van Vooren S; Boelens J; De Waele J
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263
[TBL] [Abstract][Full Text] [Related]
2. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM.
Sadilová K; Halačová M; Černý D
Ceska Slov Farm; 2020; 69(1):17-23. PubMed ID: 32460506
[TBL] [Abstract][Full Text] [Related]
4. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
[TBL] [Abstract][Full Text] [Related]
5. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
Abdulla A; Ewoldt TMJ; Hunfeld NGM; Muller AE; Rietdijk WJR; Polinder S; van Gelder T; Endeman H; Koch BCP
BMC Infect Dis; 2020 Jan; 20(1):57. PubMed ID: 31952493
[TBL] [Abstract][Full Text] [Related]
6. Study protocol for ADAPT-TDM: A beta-lactam antibiotic Dose AdaPtation feasibility randomised controlled Trial using Therapeutic Drug Monitoring.
Pai Mangalore R; Chai MG; Pope J; Lee SJ; Padiglione A; Diehl A; Roberts L; Sim K; Rawson-Harris P; Wicha S; Schneider HG; Peel TN; Jenney A; Ayton D; Peleg AY; Udy AA
BMJ Open; 2024 Jul; 14(6):e083635. PubMed ID: 38951004
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit.
Williams P; Cotta MO; Roberts JA
Semin Respir Crit Care Med; 2019 Aug; 40(4):476-487. PubMed ID: 31585474
[TBL] [Abstract][Full Text] [Related]
8. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic Stewardship and Therapeutic Drug Monitoring of β-Lactam Antibiotics: Is There a Link? An Opinion Paper.
Richter DC; Heininger A; Chiriac U; Frey OR; Rau H; Fuchs T; Röhr AC; Brinkmann A; Weigand MA
Ther Drug Monit; 2022 Feb; 44(1):103-111. PubMed ID: 34857694
[TBL] [Abstract][Full Text] [Related]
10. A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients.
Abdulla A; Ewoldt TMJ; Purmer IM; Muller AE; Gommers D; Endeman H; Koch BCP
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):359-368. PubMed ID: 33463382
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?
Muller AE; Huttner B; Huttner A
Drugs; 2018 Mar; 78(4):439-451. PubMed ID: 29476349
[TBL] [Abstract][Full Text] [Related]
12. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
Hayashi Y; Lipman J; Udy AA; Ng M; McWhinney B; Ungerer J; Lust K; Roberts JA
Int J Antimicrob Agents; 2013 Feb; 41(2):162-6. PubMed ID: 23153962
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
Veiga RP; Paiva JA
Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper
Abdul-Aziz MH; Alffenaar JC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA; ; ; ;
Intensive Care Med; 2020 Jun; 46(6):1127-1153. PubMed ID: 32383061
[TBL] [Abstract][Full Text] [Related]
15. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
Charmillon A; Novy E; Agrinier N; Leone M; Kimmoun A; Levy B; Demoré B; Dellamonica J; Pulcini C
Clin Microbiol Infect; 2016 Jul; 22(7):625-31. PubMed ID: 27145210
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic monitoring of antibiotics: New methodologies: biosensors].
Soto D; Silva C; Andresen V M; Soto N; Wong KY; Andresen M
Rev Med Chil; 2015 Aug; 143(8):1050-7. PubMed ID: 26436935
[TBL] [Abstract][Full Text] [Related]
17. The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting.
Pai Mangalore R; Peel TN; Udy AA; Peleg AY
J Antimicrob Chemother; 2023 Oct; 78(10):2395-2405. PubMed ID: 37466209
[TBL] [Abstract][Full Text] [Related]
18. Ensuring target concentrations of antibiotics in critically ill patients through dose adjustment.
Gorham J; Taccone FS; Hites M
Expert Opin Drug Metab Toxicol; 2022 Mar; 18(3):177-187. PubMed ID: 35311440
[TBL] [Abstract][Full Text] [Related]
19. Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured review.
Carlier M; Stove V; Wallis SC; De Waele JJ; Verstraete AG; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Oct; 46(4):367-75. PubMed ID: 26271599
[TBL] [Abstract][Full Text] [Related]
20. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
